Abbott begins study of less-invasive spine implant (Reuters


Reuters - Abbott Laboratories Inc. on Wednesday
said it has begun enrolling patients in an early-stage U.S.
study of a less-invasive spinal implant aimed at patients with
mild to moderate degenerative disc disease.